Evidence map›Paper›PMID 41239241›Full record

ArticleBMC musculoskeletal disorders2025

Unveiling risk factors and predicting osteoporosis through bone density based aging model: a community-based cohort in Guangdong, China.

Jinhong Tan, Jijun Zhu, Yongtao He, Zhaohao Fan, Fuqiang Cai, Haowen Zhuang, Yanhua Hu, Kangyan Liu, Qiancheng Li, Bo Feng and 4 more

Abstract read
In one paragraph

Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jinhong Tan *Department of Osteoporosis, Lunjiao Hospital of Shunde District, Foshan, China.
Jijun Zhu *Center for Intelligent Medicine, Greater Bay Area Institute of Precision Medicine (Guangzhou), School of Life Sciences, Fudan University, Guangzhou, China.
Yongtao HeDepartment of Orthopedics, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Zhaohao FanDepartment of Osteoporosis, Lunjiao Hospital of Shunde District, Foshan, China.
Fuqiang CaiCenter for Intelligent Medicine, Greater Bay Area Institute of Precision Medicine (Guangzhou), School of Life Sciences, Fudan University, Guangzhou, China.
Haowen ZhuangCenter for Intelligent Medicine, Greater Bay Area Institute of Precision Medicine (Guangzhou), School of Life Sciences, Fudan University, Guangzhou, China.
Yanhua HuCenter for Intelligent Medicine, Greater Bay Area Institute of Precision Medicine (Guangzhou), School of Life Sciences, Fudan University, Guangzhou, China.
Kangyan LiuDepartment of Orthopedics, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Qiancheng LiDepartment of Osteoporosis, Lunjiao Hospital of Shunde District, Foshan, China.
Bo FengDepartment of Osteoporosis, Lunjiao Hospital of Shunde District, Foshan, China.
Yushi GuoDepartment of Osteoporosis, Lunjiao Hospital of Shunde District, Foshan, China.
Gan LiDepartment of Orthopedics, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Bin Wang *Center for Organoid and Regenerative Medicine, Greater Bay Area Institute of Precision Medicine (Guangzhou), School of Life Sciences, Fudan University, Guangzhou, China. wangbin@ipm-gba.org.cn.
Junfang Chen *Center for Intelligent Medicine, Greater Bay Area Institute of Precision Medicine (Guangzhou), School of Life Sciences, Fudan University, Guangzhou, China. junfang_chen@fudan.edu.cn.

Funding

National Natural Science Foundation 32370639Natural Science Foundation of Guangdong Province 2024A1515012116the Greater Bay Area Institute of Precision Medicine (Guangzhou) I0007the Greater Bay Area Institute of Precision Medicine (Guangzhou) I0028
6 · The paper itself

Abstract

backgroundOsteoporosis is a progressive skeletal disorder influenced by multiple clinical and lifestyle factors. Early identification of individuals at high risk is essential for prevention and personalized management. This study aimed to identify key determinants of osteoporosis and to establish a bone density based aging model to evaluate deviations in bone health.

methodsThis retrospective study included 4,275 adults from Shunde District, Guangdong, China (mean age 60.62 years, 67.36% female). Bone mineral density (BMD) was measured at the lumbar spine (L2-L4) and proximal femur sites (femoral neck and trochanter) using dual-energy X-ray absorptiometry (DXA). Participants were classified as normal, osteopenic, or osteoporotic according to WHO and Chinese guidelines. Univariable and multivariable regression models were applied to assess the associations between clinical and lifestyle factors and osteoporosis risk. A bone density aging model was developed using support vector regression to estimate bone density age, and bone density age acceleration (BDAA) was calculated as a marker of deviation from age-matched bone health.

resultsRisk analyses identified age, sex, body mass index, exercise frequency, OSTA score, and post-menopausal years (in women) as significant risk factors for osteoporosis. The bone density aging model showed good predictive performance (mean absolute error = 5.716 years, R² = 0.145). Higher BDAA was positively correlated with osteoporosis risk across bone health categories, including individuals without clinical diagnosis. In addition, sex-specific analyses showed that BDAA was elevated in male with insufficient exercise or smoking, and in female with osteopenia and osteoporosis, with the increase being more pronounced in osteoporosis patients, particularly under the influence of diet and alcohol consumption.

conclusionsOur findings indicate that the bone density based biological aging models can effectively capture deviations in bone health, improve early identification and personalized risk stratification of osteoporosis. This approach may facilitate and support the development of precision medicine strategies in osteoporosis prevention and management.

trial registrationNot applicable.

Indexed as

AgingBone DensityOsteoporosisAbsorptiometry, PhotonAgedChinaFemaleHumansLumbar VertebraeMaleMiddle AgedRetrospective StudiesRisk AssessmentRisk Factors

Identifiers

PMID41239241
PMCPMC12619419

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.